Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.74 |
| ▸ | GAA | P10253 | 8/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.74 |
| ▸ | MEN1 | O00255 | 3/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.74 |
| ▸ | LMNA | P02545 | 2/20 | 0.74 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.68 |
| ▸ | HPGD | P15428 | 2/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | APP | P05067 | 1/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | SNCA | P37840 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7166997 | 0.91 | MAPT (0.75) | MAPTGAAKDM4EALDH1A1MEN1 | |
| SCHEMBL9183066 | 0.89 | MAPT (0.69) | MAPTGAAKDM4EALDH1A1MEN1 | |
| SCHEMBL4607773 | 0.87 | MAPT (0.86) | MAPTGAAKDM4EALDH1A1MEN1 | |
| SCHEMBL217480 | 0.85 | MAPT (1.00) | MAPTGAAKDM4EALDH1A1MEN1 | |
| SCHEMBL29388147 | 0.85 | MAPT (1.00) | MAPTGAAKDM4EALDH1A1MEN1 | |
| SCHEMBL2944533 | 0.85 | MAPT (0.69) | MAPTGAAKDM4EALDH1A1MEN1 | |
| SCHEMBL2508112 | 0.85 | MAPT (0.61) | MAPTGAAKDM4EALDH1A1MEN1 | |
| SCHEMBL2677107 | 0.84 | MAPT (0.71) | MAPTGAAKDM4EALDH1A1MEN1 | |
| SCHEMBL17533031 | 0.83 | MAPT (0.64) | MAPTGAAKDM4EALDH1A1MEN1 | |
| SCHEMBL6576141 | 0.83 | MAPT (0.95) | MAPTGAAKDM4EALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2224790-B1 | Light emitting element and azole compound | UDC IRELAND LTD (IE) | 2013-01-02 | — | — | EP | disclosed |
| US-7838131-B2 | Light emitting element and azole compound | FUJIFILM CORPORATION (JP) | 2010-11-23 | — | — | US | disclosed |
| EP-1175128-B1 | Light emitting element and azole compound | FUJIFILM CORP (JP) | 2010-09-22 | — | — | EP | disclosed |
| EP-2224790-A1 | Light emitting element and azole compound | Fujifilm Corporation (JP) | 2010-09-01 | — | — | EP | disclosed |
| US-20100044638-A1 | 1,3,5-Tri((2-(methyl-)benzimidazol-1-yl)-)benzene; OLED'shaving a light emission maximum wavelength of 500 nm or less wherein the minimum excitation triplet energy level of the host material is higher than the minimum excitation triplet energy level of the light emitting material | FUJIFILM CORPORATION (JP) | 2010-02-25 | — | — | US | disclosed |
| US-7632579-B2 | Light emitting element and azole compound | FUJIFILM CORPORATION (JP) | 2009-12-15 | — | — | US | disclosed |
| US-20050260452-A1 | Light emitting element and azole compound | FUJI PHOTO FILM CO., LTD. | 2005-11-24 | — | — | US | disclosed |
| US-6962755-B2 | Light emitting element and azole compound | FUJI PHOTO FILM CO., LTD. (JP) | 2005-11-08 | — | — | US | disclosed |
| US-20020028329-A1 | Light emitting element and azole compound | FUJI PHOTO FILM CO., LTD. | 2002-03-07 | — | — | US | disclosed |
| EP-1175128-A2 | Light emitting element and azole compound | FUJI PHOTO FILM CO., LTD. (JP) | 2002-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020028329-A1 | Light emitting element and azole compound | CRY1, CRY2, EML4 | MAPT 207/4885GAA 4304/4885KDM4E 833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.